A Unique Biomedical Treatment For The Suppression of Diabetes and Obesity

Unique and efficient means for controlling obesity, diabetes, and osteoporosis. Background: Obesity and diabetes have reached crisis proportions. Exercise is perhaps the single, common "intervention" recognized as a deterrent to these diseases, yet the manner in which load-bearing suppresses their pathogenesis remains unknown, or even if there is a common pathway whereby mechanical signals can regulate insulin production or the metabolism of fat. Technology Overview: Dr. Clinton Rubin, professor and chair in the Department of Biomedical Engineering at Stony Brook University has demonstrated that short periods of extremely low magnitude mechanical signals are anabolic to bone if applied at a high frequency.Hypothesized as a surrogate for the spectral content of muscle contractibility lost with aging and inactivity, the potential of these signals to to the clinic as a non-pharmacologic intervention for osteoporosis has been supported by a series oftrials. This technology represents a unique means for the control of obesity, diabetes, and osteoporosis. Advantages: First non-drug, non-excersize based intervention for the control and reversal of obesity and diabetes. Non-pharmacologic means for the control of insulin production and glucose tolerance. Applications: Control of obesity, diabetes, and osteoporosis. Intellectual Property Summary: PCT Publication No. WO 2007-137123 Stage of Development: Proof of concept data is available. Licensing Potential: Licensing Status: Exclusive License - All Fields Additional Information: Obesity, Diabetes, Osteoporosis, Mechanical, Frequency, Glucose, Vibration, Non-drug, Fat, Adipose, Insulin, Adipogenesis, Free fatty acid, Triglycerides https://stonybrook.technologypublisher.com/files/sites/therapeutics1.jpg
Patent Information:
Technology/Start-up ID: